Key result
Mitochondrial KATP channels mediate ischemic preconditioning and represent potential targets for anti-ischemic therapies.
Why the study?
The mechanisms underlying ischaemic pre-conditioning and the role of cardiac ATP-sensitive potassium channels in cardioprotection are not yet fully understood, and selective K(ATP) channel modulators are being explored as potential anti-ischaemic therapies.
Comparison
K(ATP) channel activators versus blockers
Design
Review of experimental evidence and pharmacological profiles
Authors
Loading...
Supports pursuit of mitochondrial K(ATP)-selective agents; leaves open clinical validation in ischaemic heart disease.
Molecules exhibiting selectivity towards mitochondrial K(ATP) channels are highlighted as potential anti-ischaemic cardio-protective pharmacological tools.
Testai et al. (2007) conducted a review in Myocardial ischaemia. K(ATP) channel modulators was evaluated. Cardiac ATP-sensitive potassium channels, particularly mitochondrial K(ATP) channels, play a crucial role in ischaemic pre-conditioning and represent potential targets for anti-ischaemic therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: